Lopid P-D 737
Generic Name: gemfibrozil
Pill imprint Lopid P-D 737 has been identified as Lopid 600 mg.
Lopid is used in the treatment of high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Lopid 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Lopid Images
- Generic Name:
- gemfibrozil
- Imprint:
-
Lopid
P-D 737 - Strength:
- 600 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium stearate
candelilla wax
microcrystalline cellulose
hydroxypropyl cellulose
hypromellose
methylparaben
polyethylene glycol
polysorbate 80
propylparaben
silicon dioxide
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00071-0737
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-1418 | Physicians Total Care Inc (repackager) |
| 00247-1022 | Prescript Pharmaceuticals (repackager) |
Note: Inactive ingredients may vary.


